Signaling Pathways - IRAK - MARK1 - RAD51 - Insulin and Insulin-like Receptors
清除全部
- B5881 RI-2Target: RAD51Summary: RAD51抑制剂
- A8440 GSK1838705ATarget: Insulin and Insulin-like Receptors|ALKSummary: ATP竞争性IGF-IR/IR/ALK抑制剂
- A1302 GSK1904529ATarget: Insulin and Insulin-like ReceptorsSummary: IGF-1R/IR 选择性抑制剂
- A1185 BMS-754807Target: Insulin and Insulin-like ReceptorsSummary: 有效的、选择性的IGF-1R和InsR抑制剂
- A3764 RI-1Target: RAD51Summary: RAD51抑制剂
- A3635 MRT67307 HClTarget: TBK1|MARK1|NUAK1Summary: SIK/TBK-1/IKKe抑制剂
- A3608 MK 0893Target: Insulin and Insulin-like Receptors|Glucagon ReceptorsSummary: 胰高血糖素受体/ IGF-1R拮抗剂
- A3505 IRAK-1-4 Inhibitor I3 CitationTarget: IRAKSummary: IRAK-1/4抑制剂
- A3504 IRAK inhibitor 6Target: IRAKSummary: IRAK-4抑制剂
- A3503 IRAK inhibitor 4Target: IRAKSummary: IRAK抑制剂